USE OF THE PROBIOTIC Lactobacillus reuteri DSM 17938 IN THE PREVENTION OF ANTIBIOTIC-ASSOCIATED INFECTIONS IN HOSPITALIZED BULGARIAN CHILDREN: A RANDOMIZED, CONTROLLED TRIAL

USE OF THE PROBIOTIC Lactobacillus reuteri DSM 17938 IN THE PREVENTION OF ANTIBIOTIC-ASSOCIATED INFECTIONS IN HOSPITALIZED BULGARIAN CHILDREN: A RANDOMIZED, CONTROLLED TRIAL

Objective: To evaluate the effectiveness of Lactobacillus reuteri DSM 17938 for the prevention of antibiotic-associated diarrhoea and Clostridium difficile-related infections in hospitalized children in a Bulgarian hospital. Study design: Children (n=100, aged 3 to 12 years) admitted to the hospit...

Full description

Bibliographic Details
Main Authors:	Miglena Georgieva, Ruzha Pancheva, Niya Rasheva, Nataliya Usheva, Liliya Ivanova, Krassimira Koleva
Format:	Article
Language:	English
Published:	Peytchinski Publishing 2015-10-01
Series:	Journal of IMAB
Subjects:	Probiotic Lactobacillus reuteri Clostridium difficile antibiotic associated diarrhoea childhood
Online Access:	http://www.journal-imab-bg.org/issues-2015/issue4/JofIMAB_2015-21-4p895-900.pdf

Similar Items

Lactobacillus reuteri DSM 17938 and quality of life associated with functional constipation
by: Asburce Olgac, et al.
Published: (2020-09-01)

Lactobacillus Reuteri DSM 17938 <i>(Limosilactobacillus reuteri)</i> in Diarrhea and Constipation: Two Sides of the Same Coin?
by: Angela Saviano, et al.
Published: (2021-06-01)

Probiotic Lactobacillus reuteri DSM 17938: what is known about it today?
by: I. N. Zakharova, et al.
Published: (2019-11-01)

Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting
by: Ener Cagri Dinleyici, et al.
Published: (2015-07-01)

Wheat and Sugar Beet Coproducts for the Bioproduction of 3-Hydroxypropionic Acid by Lactobacillus reuteri DSM17938
by: Julien Couvreur, et al.
Published: (2017-07-01)

Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting
by: Ener Cagri Dinleyici, et al.
Published: (2015-08-01)

Intoleransi Minum pada Neonatus Kurang Bulan dan Lactobacillus Reuteri DSM 17938
by: Risma Kerina Kaban
Published: (2022-04-01)

Effects of Lactobacillus reuteri DSM 17938 in preterm infants: a double-blinded randomized controlled study
by: Xuewei Cui, et al.
Published: (2019-11-01)

A systematic review and meta-analysis: the therapeutic and preventive effect of Lactobacillus reuteri DSM 17,938 addition in children with diarrhea
by: Xiaoqi Sun, et al.
Published: (2023-05-01)

Impact of the fermentation parameters pH and temperature on stress resilience of Lactobacillus reuteri DSM 17938
by: Armando Hernández, et al.
Published: (2019-05-01)

Antibiofilm activity and NMR-based metabolomic characterization of cell-free supernatant of Limosilactobacillus reuteri DSM 17938
by: Irene Vitale, et al.
Published: (2023-02-01)

Human Skin Bacterial Community Response to Probiotic (<i>Lactobacillus reuteri</i> DSM 17938) Introduction
by: Marie Frerejacques, et al.
Published: (2020-08-01)

Quantitative evaluation of synbiotic strategies to improve persistence and metabolic activity of Lactobacillus reuteri DSM 17938 in the human gastrointestinal tract
by: Monchaya Rattanaprasert, et al.
Published: (2014-09-01)

Efecto de diferentes formulaciones preparadas con cereales y leguminosas sobre el crecimiento de Lactobacillus reuteri DSM 17938
by: Yasmina Barboza, et al.
Published: (2024-01-01)

Correlation between the Antimicrobial Activity and Metabolic Profiles of Cell Free Supernatants and Membrane Vesicles Produced by <i>Lactobacillus reuteri</i> DSM 17938
by: Alessandro Maccelli, et al.
Published: (2020-10-01)

Diarrhoea in critical care patients: focus on special issues
by: Maurizio Ventrucci, et al.
Published: (2013-05-01)

Lactobacillus reuteri DSM 17938 Probiotics May Increase CC-Chemokine Receptor 7 Expression in Infants Treated With for Colic
by: Francesco Savino, et al.
Published: (2019-07-01)

Orodispersible lozenges containing a combination of Lactobacillus reuteri DSM 17938 and Lactobacillus reuteri ATCC PTA 5289 and normal gum function: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
by: EFSA Panel on Nutrition, Novel foods and Food Allergens (NDA), et al.
Published: (2020-03-01)

Enteroadsorbent Polymethylsiloxane Polyhydrate vs. Probiotic Lactobacillus reuteri DSM 17938 in the Treatment of Rotaviral Gastroenteritis in Infants and Toddlers, a Randomized Controlled Trial
by: Leo Markovinović, et al.
Published: (2020-12-01)

Effect of drops containing Lactobacillus reuteri (DSM 17938 and ATCC PTA 5289) on plaque acidogenicity and other caries-related variables in orthodontic patients
by: Sahal Alforaidi, et al.
Published: (2021-10-01)

Clostridium difficile in Antibiotic-Associated Diarrhoea and Detection of Toxin Producing Strains in a Tertiary Care Hospital in Western Maharashtra
by: Priyanka M. Mane, et al.
Published: (2019-01-01)

Mortality and <it>Clostridium difficile</it> infection: a review
by: Mitchell Brett G, et al.
Published: (2012-05-01)

Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight < 1000 grams: a sequential analysis
by: Hunter Chelsea, et al.
Published: (2012-09-01)

Is the Incidence of Clostridium difficile in Nosocomial Diarrhoea Underestimated?
by: Özer AKGÜL, et al.
Published: (2018-06-01)

Postbiotic Modulation of Retinoic Acid Imprinted Mucosal-like Dendritic Cells by Probiotic Lactobacillus reuteri 17938 In vitro
by: Yeneneh eHaileselassie, et al.
Published: (2016-03-01)

Limosilactobacillus reuteri DSM 17938 and ATCC PTA 6475 for the treatment of moderate to severe irritable bowel syndrome in adults: a randomized controlled trial
by: Silvia Cruchet, et al.
Published: (2024-01-01)

Вплив застосування комбінації Lactobacillus reuteri DSM 17938 із вітаміном D на рівень 25(ОН)D у сироватці крові дітей раннього віку
by: M.E. Mamenko, et al.
Published: (2020-09-01)

Safety and efficacy of Lactobacillus reuteri NBF‐2 (DSM 32264) as a feed additive for cats
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2019-01-01)

Safety and efficacy of Lactobacillus reuteri NBF‐1 (DSM 32203) as a feed additive for dogs
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2019-01-01)

<i>Lactobacillus reuteri</i> DSM 17938 as a Novel Topical Cosmetic Ingredient: A Proof of Concept Clinical Study in Adults with Atopic Dermatitis
by: Éile Butler, et al.
Published: (2020-07-01)

Prevalence of and factors associated with inappropriate Clostridioides difficile testing in a teaching hospital in Korea
by: Hee Bum Jo, et al.
Published: (2022-05-01)

A prospective cross sectional study of detection of Clostridium difficile toxin in patients with antibiotic associated diarrhoea
by: Arun Sachu, et al.
Published: (2018-02-01)

<i>L. reuteri</i> DSM 17938: from the history of the discovery of the strain to the emergence of evidence-based studies (strain specificity)
by: O. V. Dedikova, et al.
Published: (2022-07-01)

A high-dose preparation of lactobacilli and bifidobacteria in the prevention of antibiotic-associated and Clostridium difficile diarrhoea in older people admitted to hospital: a multicentre, randomised, double-blind, placebo-controlled, parallel arm trial (PLACIDE)
by: SJ Allen, et al.
Published: (2013-12-01)

<em>Lactobacillus reuteri</em> DSM 17938 and Agave Inulin in Children with Cerebral Palsy and Chronic Constipation: A Double-Blind Randomized Placebo Controlled Clinical Trial
by: Andrea A. García Contreras, et al.
Published: (2020-09-01)

<i>Lactobacillus plantarum</i> and <i>Lactobacillus reuteri</i> as Functional Feed Additives to Prevent Diarrhoea in Weaned Piglets
by: Matteo Dell’Anno, et al.
Published: (2021-06-01)

Presumably hospital-transmitted Clostridium difficile infections based on epidemiological linkage
by: Philipp Kohler, et al.
Published: (2013-07-01)

Proton pump inhibitors and risk for Clostridium difficile associated diarrhea
by: Sasmita Biswal
Published: (2014-08-01)

Clostridium difficile infections among adults and children in Mwanza/Tanzania: is it an underappreciated pathogen among immunocompromised patients in sub-Saharan Africa?
by: M. Seugendo, et al.
Published: (2015-11-01)

Conventional and molecular methods in the diagnosis of community-acquired diarrhoea in children under 5 years of age from the north-eastern region of Poland
by: Krzysztof Fiedoruk, et al.
Published: (2015-08-01)